drug
indomethacin
Marketedupdated 3mo agoby ACP Nimble Buyer Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4all catalysts(0)
nothing on the calendar yet
Trials studying indomethacin
- phase1Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)
- phase2IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3
- phase4A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of Acute Gout (0663-081)(COMPLETED)
- phase2IRX-2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity
- phase1A First Time in Human Study to Evaluate the Safety and Tolerability of GSK4381406 in Healthy Participants
- phase3Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing Spondylitis
Patent cliff
source: FDA Orange Bookfirst barrier falls
Apr 23, 2030
~3.7 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (6)
- Apr 23, 2030formulationUS 87348473.7y
- Apr 23, 2030formulationUS 87348473.7y
- Apr 23, 2030formulationUS 89929823.7y
- Apr 23, 2030formulationUS 89929823.7y
- Apr 23, 2030method-of-use (U-55)US 90894713.7y
- Apr 23, 2030method-of-use (U-55)US 90894713.7y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that